Comment on CMS-2026-1255-0001
Crohn's & Colitis FoundationSupportAdvocacy
Summary: The Crohn’s & Colitis Foundation, representing over 1,200 patients, providers, and caregivers, supports the proposed rule to standardize and streamline electronic prior authorization for drugs. They urge CMS to further strengthen patient protections by establishing rigorous federal safeguards, standardized exception processes, and continuity-of-care protections for step therapy.
Attached please find comments from the Crohn's & Colitis Foundation and from the patients that we represent.